Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders including dementia with Lewy bodies (DLB), had the opportunity to raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback